PCI to invest $20m in biologic medicines and advanced injectable delivery forms
PCI Pharma Services (PCI) will invest over $20m to expand its biotech technologies, including advanced injectable delivery forms, at multiple locations across the world, to meet demand for biotech packaging.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.